Arca
Skip to content

Coronary artery disease

Drug research and approvals for coronary artery disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 1,248 studies of coronary artery disease are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and the EU has 6 authorised medicines for it.

  • Recruiting worldwide: 1,248
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 0
  • EU medicines: 6

Recruiting Now

Newest start dates first, of 1,248 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jul 20, 2023A phase 3, multicenter, open label study to confirm the diagnostic potential of intravenously administered 15o-h2o to identify coronary artery disease during…[15O]-H2O FOR INJECTIONMEDTRACE PHARMA A/SClosed
Jul 6, 2022A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IIIb study evaluating the effect of inclisiran on atherosclerotic plaque…INCLISIRAN (KJX839)Novartis Pharmaceuticals CorporationOngoing
Jun 7, 2019A phase 3, open-label, multicentre study of flurpiridaz (18f) injection for positron emission tomography (pet) imaging for assessment of myocardial perfusion…FLURPIRIDAZ (18F) INJECTIONGEClosed
Dec 19, 2017A multi-center, double-blind, randomized, placebo-controlled study to assess the pharmacodynamics, pharmacokinetics, tolerability, and safety of a single…ACT-246475IDORSIA PHARMACEUTICALS LTDClosed
Dec 18, 2014A phase 2, randomized, double-blind, placebo controlled, parallel study of gs-6615 in subjects with chronic stable angina and coronary artery diseaseGS-6615Gilead SciencesPending

Medicines Authorised in the EU

Newest first
May 22, 2017Ivabradine Accordivabradine · genericAccord Healthcare S.L.U.EMA ↗
Nov 11, 2016Ivabradine Zentivaivabradine · genericZentiva k.s.EMA ↗
Sep 8, 2015Ivabradine Anpharmivabradine"Anpharm" Przedsiębiorstwo Farmaceutyczne S.A.EMA ↗
Mar 23, 2015KengrexalcangrelorChiesi Farmaceutici S.p.A.EMA ↗
Oct 25, 2005CorlentorivabradineLes Laboratoires ServierEMA ↗
Oct 25, 2005ProcoralanivabradineLes Laboratoires ServierEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.